Dr Reddy’s shares crash 9% in 2 days; brokerages slash target prices after semaglutide supply disruption. What lies ahead?

Dr Reddy’s Laboratories shares extended their decline after the company delayed commercial supplies of its semaglutide product due to a quality-related API issue. While brokerages remain broadly positive on the long-term outlook, several have cut target prices and earnings estimates, citing near-term execution risks and slower product ramp-up.

Vedanta Power, Vedanta Oil & Gas, other Vedanta stocks surge up to 6%. What lies ahead?

Vedanta Group stocks experienced significant gains on Friday after their recent demerger. Vedanta Iron and Steel shares surged five percent, hitting the upper circuit limit. Vedanta Oil and Gas shares also saw a substantial increase, extending recent positive momentum. Vedanta Power and Vedanta Aluminium reported production and sales figures for the first quarter. Analysts at…